SOTK

Sono-Tek is a genuinely high-quality micro-cap: the self-described world leader in ultrasonic spray-coating systems, debt-free, with $14.8M of cash and marketable securities against an $83.9M market cap and a pristine balance sheet (liabilities/equity just 0.34x, equity $19.8M). FY2026 was a record year on every profitability line — net income $1.81M (+42%), operating income $1.82M (+81%), gross margin expanding to 51% from 48% on favorable mix and more domestic system shipments, and operating cash flow surging to $3.25M. The mix shift the company has been chasing — away from commodity nozzles toward high-ASP integrated production systems (Integrated Coating Systems +91%, Medical +54% on drug-eluting balloon/stent/diagnostic demand, US/Canada +12%) — is clearly showing up in the margin structure, and the record $9.12M year-end backlog supports near-term revenue visibility. This is a real, profitable, durable franchise, not a story stock.

The problem is the price, not the business. Revenue grew just 2% to $20.9M, and the headline earnings jump is largely margin recovery off a depressed base rather than top-line acceleration — note that FY2026 net income of $1.81M still sits below the $2.54M earned back in FY2022 on lower revenue, and the five-year revenue line ($17.1M → $15.1M → $19.7M → $20.5M → $20.9M) is lumpy and project-driven, not a smooth compounder. At $5.34 the stock trades at 48.5x diluted EPS of $0.11 and 4.0x sales while generating a 9.1% ROE and an 8.6% net margin. That multiple prices in a re-acceleration the recent top line hasn't delivered. Strip out the ~$14.8M cash and the operating business is still ~38x operating income — rich for a 2%-grower in cyclical industrial capital equipment.